Brett W. Davies

Brett W. Davies ( BRETT W. DAVIES ) is A Ophthalmology Physician in Jbsa Lackland, TX. The NPI Number for Brett W. Davies is 1497959746.

The current location address for Brett W. Davies is 1100 WILFORD HALL LOOP BLDG 4554 Jbsa Lackland, TX 78236 and the contact number is 2102926225 and fax number is . The mailing address for Brett W. Davies is 1100 WILFORD HALL LOOP, BLDG 4554 ATTN: 59 MDW/SGHC JBS Jbsa Lackland, TX 78236- 2102926225 (mailing address contact number - 2102926225).

A physician who specializes in oculofacial plastic and reconstructive surgery. This subspecialty combines orbital and periocular surgery with facial plastic surgery, and includes aesthetic and reconstructive surgery of the face, orbit, eyelid, and lacrimal system. Practitioners evaluate, diagnose and treat conditions involving the eyelids, brows, midface, orbits, lacrimal systems and surrounding and supporting structures of the face and neck.

What is the NPI Number for Brett W. Davies ?

Answer: The NPI Number for Brett W. Davies is 1497959746

Where is Brett W. Davies located?

Answer: Brett W. Davies is located at 1100 WILFORD HALL LOOP BLDG 4554 Jbsa Lackland, TX 78236.

What is the specialty for Brett W. Davies ?

Answer: The Specialty of Brett W. Davies is A Ophthalmology Physician.

Are there any online reviews for Brett W. Davies ?

Answer: Yes! Check It Now.

Are there any other health care providers in Jbsa Lackland, TX?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Brett W. Davies

Number of HCPCS	37
Number of Medicare Beneficiaries	172
Number of Services	710
Total Submitted Charge Amount	190585
Total Medicare Allowed Amount	78258.46
Total Medicare Payment Amount	59671.2
Total Medicare Standardized Payment Amount	62759.75
Drug Suppress Indicator	*
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator	#
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries	74
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74	108
Number of Beneficiaries Age 75 to 84	50
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	116
Number of Male Beneficiaries	56
Number of Non-Hispanic White Beneficiaries	149
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement
Number of Beneficiaries With Medicare Only Entitlement
Percent (%) of Beneficiaries Identified With Atrial Fibrillation	0.11
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0.07
Percent (%) of Beneficiaries Identified With Asthma	0.06
Percent (%) of Beneficiaries Identified With Cancer	0.07
Percent (%) of Beneficiaries Identified With Heart Failure	0.13
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.19
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.07
Percent (%) of Beneficiaries Identified With Depression	0.17
Percent (%) of Beneficiaries Identified With Diabetes	0.21
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.65
Percent (%) of Beneficiaries Identified With Hypertension	0.57
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.24
Percent (%) of Beneficiaries Identified With Osteoporosis	0.11
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.47
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries	0.9459

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Ophthalmology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	107
Number of Standardized 30-Day Fills	107
Aggregate Cost Paid for All Claims	1001.21
Number of Day's Supply for All Claims	559
Number of Medicare Beneficiaries	78
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	105
Aggregate Cost Paid for Generic Drugs	899.11
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	29
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	250.23
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	78
Aggregate Cost Paid for Claims Filled by	750.98
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	#
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	69
Aggregate Cost Paid for Opioid Drugs	285.14
Opioid Claims	64
Opioid_Tot_Clms divided by the Tot_Clms	64.485981308
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the	0
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims	0
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	73.512820513
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	47
Number of Male Beneficiaries	31
Number of Non-Hispanic White	68
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	0.9601153846